medigraphic.com
ISSN 1561-302X (Print)

2012, Number 2

<< Back Next >>

Rev cubana med 2012; 51 (2)

Giant tumor in a patient with melanoma

Selman-Housein BKH, Tárano QG, Morales PI, Alfonso SC, Hernández BF

Language: Spanish
References: 19
Page: 183-190
PDF size: 217.64 Kb.


ABSTRACT

The case of a black Caribbean patient aged 17 apparently healthy until 2007 when to appear a left temporal-parietal-frontal tumor of fast growth involving the face. At physical examination authors also confirmed a pale skin and mucosae with a severe malnutrition. The histopathological diagnosis was a malignant melanoma of epithelioid cells.


REFERENCES

  1. Estape-Rodríguez J, Grau de Castro JJ. Historia natural y factores etiológicos del cáncer. Oncología Médica. 2005:1168-9.

  2. Swerlick RA, Chen S. The melanoma epidemic: more apparent than real? Mayo Clin Proc. 1997;72:559-64.

  3. Diepgen TL, Mahler VM. The epidemiology of skin cancer. Br J Dermatol. 2002;146(61):1-6.

  4. Charles CA, Marghoob AA, Busam KJ. Melanoma or pigmented basal cell carcinoma: a clinical-pathologic correlation with dermoscopy, in vivo confocal scanning laser microscopy, and routine histology. Skin Res Technol. 2002;8:282-7.

  5. Rigel DS, Russak J, Friedman R. The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. CA Cancer J Clin. 2010;60(5):301-16.

  6. Cockburn M, Swetter SM, Peng D, Keegan TH, Deapen D, Clarke CA. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. Melanoma. 2005;55(2):74-108.

  7. Torpy J, Lynm C, Glass MN. Melanoma. JAMA. 2004;292(22):2800.

  8. Hasney C, Butcher RB, Amedee RG. Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management. Ochsner J. 2008;8(4):181-5.

  9. Strayer SM, Reynolds P. Diagnosing skin malignancy: assessment of predictive clinical criteria and risk factors. J Fam Pract. 2003;52(3):210-8.

  10. Markovick SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, et al. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007;82:490-513.

  11. Goodson AG, Grossman D. Strategies for early melanoma detection: Approaches to the patient with nevi. J Am Acad Dermatol. 2009;60(5):719-35.

  12. Simpson CL. The ABCs of Melanoma: Expanding Basic Screening and Education. Virtual Mentor. 2006;8(8):517-9.

  13. Panajotovic L. Big Primary Cutaneous Melanoma of the Scalp - Case Report. ANZ J Surg. 2003; 73 Suppl 2:A310.

  14. Díaz de Corcuera I, Arévalo-Lobera S, Basterretxea L, Otaño E, Mínguez J, Lacasta Muñoa A. Un caso de melanoma maligno meníngeo en un varón adulto que debuta con paraplejia. Oncología. 2004;27:9.

  15. Harting M, Tarrant W, Kovitz CA, Rosen T, Harting MT, Souchon E. Massive nodular melanoma. Dermatology Online Journal 2007;13(2):7. [citado noviembre de 2011]. Disponible en: http://dermatology.cdlib.org/132/case_reports/melanoma/harting.html

  16. Win-Piazza H, Schneeberger V, Chen L, Pernazza D, Lawrence HR, Sebti SM, et al. Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2. Cancer Lett. 2012 Jan 31. PMID:22306001.

  17. Gogas H, Ioannovich J, Dafni U, Stavropoulou-Giokas C, Frangia K, Tsoutsos D. Prognostic significance of autoimmunity during treatment of melanoma with interferon. NEJM 2006;16:709-18.

  18. Eggermont AM, Suciu S, Santinami M, Testori A, Kruit WH, Marsden J, et al: EORTC Melanoma Group. Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final result of EORTC 18991, a randomised phase III trial. Lancet. 2008;372(9633):117-26.

  19. Crosby T, Fish R, Coles B, Mason M. Cochrane Reviews. Systemic treatments for metastatic cutaneous melanoma, Review. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD001215. DOI: 10.1002/14651858.CD001215.




2020     |     www.medigraphic.com